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Tuesday, March 8, 2011 421apotential upstroke. These data are the first report of FGF13 as regulator ofNav1.5
in heart and suggest that FGF13 isoform-specific regulation of cardiac Nav chan-
nels plays important physiological and pathophysiological roles.
2279-Pos Board B265
CaMKII Regulates Cardiac Sodium Channel Nav1.5 by Phosphorylation
in the Loop Between Domain I and II
Anthony W. Herren, Nicole M. Ashpole, Kenneth S. Ginsburg,
Donald M. Bers, Andy Hudmon.
The cardiac Na channel NaV1.5 current (INa) is critical to cardiac excitability
and altered INa gating has been implicated in genetic and acquired arrhyth-
mias. Ca-calmodulin dependent protein kinase (CaMKII) is upregulated in
heart failure and has been shown to cause INa gating changes that mimic
a point mutant in humans associated with combined long QT and Brugada
syndromes. We sought to identify the CaMKII phosphorylation target site
on NaV1.5 that mediates the CaMKII-induced alterations in INa gating. We an-
alyzed CaMKII-dependent phosphorylation of NaV1.5 intracellularly accessi-
ble sites using a series of GST-fusion constructs, immobilized peptide arrays,
and soluble peptides. CaMKII phosphorylation sites were identified at S516
and S593/T594 in the intracellular NaV1.5 loop between domains 1 and 2.
Wild-type (WT) and phospho-mutant human Nav1.5 were co-expressed
with CaMKIIdC-GFP in HEK293 cells and INa was recorded by whole-cell
patch clamp under pipette conditions that acutely activated CaMKII (þ1
mM free [Ca], þ 1 mM Calmodulin). As observed in myocytes, CaMKII
shifted WT INa availability to more negative membrane potentials and en-
hanced accumulation of INa into intermediate inactivation, but these effects
were abolished by mutating either of the CaMKII sites to non-
phosphorylatable alanine residues (V1/2 of availability: WT 101.8 5 4.5
(n=10); S593/T594AA 89.7 5 3.5 (n=11) ; S516A 93.0 5 5.5 (n=18)).
Furthermore, the phospho-mutant channels mimicked WT INa treated with 1
mM AIP, a specific CaMKII inhibitor, and AIP had no effect on phospho-
mutant INa. CaMKII activation had no effect on the V1/2 of activation or I-
V curve shape of any channel. CaMKII-dependent phosphorylation of
NaV1.5 at multiple sites (including Ser593/Thr594 and Ser516) appears to
be required to evoke loss-of-function changes in gating that could contribute
to acquired Brugada syndrome like effects in heart failure.
2280-Pos Board B266
Chlorobutanol, a Pharmaceutical Preservative and Sedative Hypnotic,
Inhibits Brain Type Voltage Gated Sodium Channels
George Kracke, Alice Landrum.
Introduction- Chlorobutanol (1,1,1-trichloro-2-methyl-2-propanol) is a widely
used chemical preservative for injectabledrugs, eyedrops,mouthwashes, and cos-
metics. It is ananalgesic, experimental general anesthetic, and sedativehypnotic in
man. The mechanism of action of chlorobutanol is unclear. Our goal was to test
whether chlorobutanol inhibits brain type voltage gated sodium channels.
Methods- Mammalian Nav 1.2 voltage gated sodium channels were expressed
in Xenopus oocytes by injecting the alpha subunit cRNA. Inward sodium cur-
rents were measured with two-electrode voltage clamp using standard depolar-
ization protocols. The study was approved by our institutional animal care and
use committee.
Results- Chlorobutanol was tested at concentrations ranging from 0.03 to 10
mM. Chlorobutanol reversibly inhibited closed, resting channels and inacti-
vated channels in a concentration dependent manner. The voltage dependence
of activation was shifted in the depolarizing direction. Fast inactivation voltage
dependence was not affected. There was little state dependent block and no ap-
parent use dependence.
Discussion and Conclusions- Chlorobutanol inhibited Nav 1.2 channels at con-
centrations less than those used to preserve pharmaceuticals. Its use as a preser-
vative in injectable methadone and local anesthetic solutions, and in eye drops
likely adds an analgesic component to these solutions.
2281-Pos Board B267
Enhancement of Slow Inactivation of Voltage-Gated Naþ Channels by
Ranolazine
Ryoko Hirakawa, Lynda V. Liu, John C. Shryock, Luiz Belardinelli,
Sridharan Rajamani.
Ranolazine is an anti-anginal drug that blocks cardiac (Nav1.5) late Na
þ current
(INa) at therapeutic concentrations (2-10 mM). Recent electrophysiological
studies have shown that ranolazine also blocks skeletal muscle (Nav1.4) and
neuronal (Nav1.1, Nav1.7, Nav1.8) INa. We investigated the effects of ranola-
zine on peak INa and on both sustained repetitive firing (SRF) and 0 mM
Mg2þ- induced (0 [Mg2þ]O) continuous high frequency firing of action poten-
tials in cultured rat hippocampal neurons. Ranolazine caused a voltage (60
mV) and frequency (10 Hz)-dependent inhibition of INa with IC50 values of0.48 and 61.8 mM (n=4-6), respectively.
Ranolazine (10 mM, n=4) did not shift
the voltage-dependence of steady-state
fast inactivation; however, it caused
a 15-mV hyperpolarizing shift
(p<0.05, compared to control, n=4) in
the slow inactivation. Consistently, ra-
nolazine (10 mM) reduced SRF only
during a 4-sec burst but not with a 1-
sec depolarization step (Fig.1). Further-
more, ranolazine (10 mM) reduced
0 [Mg2þ]O -induced high frequency fir-
ing of spontaneous action potentials
from 0.78 to 0.45 Hz (p<0.05, n=5). Taken together, these data suggest that ra-
nolazine suppresses the propagation and conduction of action potentials by
preferentially interacting with Naþ channels in the slow inactivated state.
2282-Pos Board B268
Y1767C, a Novel SCN5A Mutation Induces a Persistent Sodium Current
and Potentiates Ranolazine Inhibition of NaV1.5 Channels
Hai Huang, Silvia G. Priori, Carlo Napolitano, Michael E. O’Leary,
Mohamed Chahine.
LongQT syndrome type 3 (LQT3) has been traced tomutations of the cardiacNa
channel (Nav1.5) that produce persistent Na currents leading to delayed ventric-
ular repolarization and Torsades de pointes. We performed mutational analyses
of patients suffering from LQTS and characterized the biophysical properties of
the mutations that we uncovered. One LQT3 patient carried a mutation in the
SCN5A gene in which the cysteine was substituted for a highly conserved tyro-
sine (Y1767C) located near cytoplasmic entrance of the Nav1.5 channel pore.
The wild-type and mutant channels were transiently expressed in tsA201 cells,
and the Na currents were recorded using the patch-clamp technique. The
Y1767C channel produced a persistent Na current, more rapid inactivation,
faster recovery from inactivation, and an increased window current. The persis-
tent Na current of the Y1767C channel was blocked by ranolazine but not by
many class I antiarrhythmic drugs. The incomplete inactivation, along with
the persistent activation of Na channels caused by an overlap of voltage-
dependent activation and inactivation, known as window currents, appeared to
contribute to the LQTS phenotype in this patient. The blocking effect of ranola-
zine on the persistent Na current suggested that ranolazine may be an effective
therapeutic for treating patients with this mutation. Our data also revealed the
unique role for the Y1767 residue in inactivating and forming the intracellular
pore of the Nav1.5 Na channel.
2283-Pos Board B269
The Selective Nav1.8 Sodium Channel Blocker A-803467 Affects Electrical
Activity in Intracardiac Neurons, but not in Cardiomyocytes
Marieke W. Veldkamp, Carol A. Remme, Brendon Scicluna,
Cees A. Schumacher, Rianne Wolswinkel, Antoni C.G. van Ginneken,
Connie R. Bezzina, Arie O. Verkerk.
Background. Recently we observed differential myocardial expression of the
brain-type sodium channel isoform Scn10a between two inbred mouse strains,
both harboring the Scn5a-1798insDþ/- mutation and displaying different se-
verity of conduction disease. The functional role of Scn10a in the heart is as
yet unknown, and we therefore investigated expression and channel activity
of NaV1.8 (encoded by Scn10a) in intracardiac neurons and myocardium of
the murine heart.
Methods. Immunocytochemistry was performed using anti-NaV1.8 antibody
on mouse embryos and adult murine cardiac tissue sections. The effect of the
NaV1.8 blocker A-803467 (500 nM) on action potentials (AP’s) and sodium
current (INa) properties was assessed in isolated intracardiac neurons and ven-
tricular myocytes.
Results. In embryonic and adult heart tissue sections, NaV1.8 staining was ob-
served at the epicardial surface, and within the myocardium in between cardio-
myocytes. The NaV1.8 blocker A-803467 had no effect on either mean INa
density or INa kinetic properties in isolated myocytes, but clearly reduced INa
density in intracardiac neurons (344551 pA/pF versus control 448561;
mean5SEM, n=11). In addition, the slow component of the current decay (tslow)
at20mVwas accelerated in thepresence ofA-803467 (2.850.3msversus con-
trol 3.450.4 ms; mean5SEM, n=5) and V1/2 of voltage-dependent inactivation
was shifted by 9.6 mV (73.652.0 mV versus control 64.051.6 mV;
mean5SEM, n=5). This is consistent with a reduction in slowly inactivating
brain-type sodium current with depolarized voltage-dependent inactivation. In
AP measurements A-803467 did not affect cardiomyocyte upstroke velocity,
but reduced AP firing frequency in intracardiac neurons by 50%.
422a Tuesday, March 8, 2011Conclusion. The sodium channel NaV1.8 is expressed in murine heart, and is
functionally present in intracardiac neurons, but absent in cardiomyocytes.
Thus, NaV1.8 may influence myocardial electrophysiological properties
through its contribution to cardiac neuronal activity.
2284-Pos Board B270
Turret Histidines in pHModulation of the Cardiac Voltage-Gated Sodium
Channel
David K. Jones, Thomas W. Claydon, Peter C. Ruben.
Low pH reduces single channel conductance and destabilizes the inactivated
states of the cardiac voltage gated sodium channel (NaV1.5) by increasing win-
dow current and inhibiting use dependent inactivation. Outer ring carboxylates
are believed to underlie proton block. In contrast, the molecular underpinnings
by which protons modulate NaV1.5 channel kinetics (Jones et al. 2010) are un-
known. We hypothesize that turret histidines found in domain II, and conserved
in all NaV channel isoforms, play a pivotal role in pH modulation and channel
function, as has been demonstrated in potassium channels (Claydon et al.
2002). We expressed wild type and mutant NaV1.5 channels in Xenopus oo-
cytes and recorded currents using a cut-open voltage clamp with extracellular
solution titrated to either pH 7.4 or pH 6.0. Replacement of a histidine with
a glutamine at position 880 abolished the effect of pH on window current
and use dependent inactivation. Additionally, the H880Q mutant depolarized
the voltage dependence of activation and fast inactivation. We therefore pro-
pose H880 plays an important role in pH modulation and function of NaV1.5.
2285-Pos Board B271
Palmitoylation Affects the Interaction of Animal Toxins with Sodium
Channels
Frank Bosmans, Mirela Milescu, Kenton J. Swartz.
Animal toxins can interact with voltage sensor paddle motifs within voltage-
activated sodium (Nav) channel voltage sensors to alter channel function.
These structural motifs were originally identified in voltage-activated potas-
sium (Kv) channels, where they were shown to move at the protein-lipid inter-
face to drive activation of the voltage sensors and opening of the pore.
Serendipitously, we identified a variant of Nav1.2 with functional properties
similar to wild-type, but that exhibits a 20-fold higher apparent affinity for
PaurTx3, a voltage sensor toxin isolated from tarantula venom. The amino
acid difference that underlies this large divergence in toxin sensitivity was
identified as G1079C and is located in the intracellular loop between domain
II and domain III of the channel. Since this region is unlikely to be directly ac-
cessible to peptide toxins applied to the external solution, we explored the pos-
sibility that cysteine palmitoylation underlies this observation. When we inhibit
palmitoylation of Nav1.2 and the G1079C mutant by using 2-Br-palmitate, the
apparent affinities of the toxin for both channels now coincide. While surveying
other molecules, we found a second tarantula toxin, ProTx-II, which is simi-
larly influenced by Nav1.2 palmitoylation. Interestingly, both these toxins in-
teract with the paddle motif in domain II of the channel whereas a scorpion
toxin that interacts with the domain IV voltage sensor, AaHII, is not affected.
These results suggest an important role for palmitoylation in shaping the phar-
macological properties of Nav1.2 and have implications for changes in drug
susceptibility of Nav channels caused by intracellular mutations.
2286-Pos Board B272
Molecular Determinants for Alpha-Scorpion Toxin Binding to the Resting
State of a Voltage Sensor of Brain Sodium Channels
Jinti Wang, Vladimir Yarov-Yarovoy, Roy Kahn, Dalia Gordon,
Michael Gurevitz, Todd Scheuer, William A. Catterall.
Voltage-gated sodium channels are responsible for initiation and propagation
of action potentials in nerve and muscle. a-Scorpion toxins, including LqhII
(Leiurus quinquestriatus hebraeus, type II), bind to the extracellular face of
the sodium channel and inhibit fast inactivation. Previous work has identified
E1613 (rat NaV1.2) in the S3-S4 loop of domain IV as a key site of toxin bind-
ing, but antibody-mapping studies suggested additional components of the
toxin receptor site in domains I and IV. To identify other determinants of toxin
action, extracellular amino acid residues in domains I and IV of the a subunit
were converted to alanine or other neutral amino acids, and mutant channels
were transiently expressed in tsA-201 cells and tested for channel function
and toxin action by whole-cell voltage clamp. Toxin affinity for most mutant
channels was unchanged from wild-type. However, electrophysiological anal-
ysis showed that T393A, T1560A, F1610A, and E1613A, had 3.4-, 5.9-, 10.7-,
and 3.9-fold lower affinities for LqhII, respectively. Most of these mutations
increased the rate of toxin dissociation, but had little effect on the rate of toxin
association. These results indicate that T1560 in the S1-S2 loop, F1610 in the
S3 segment, and E1613 in the S3-S4 loop in domain IV form one aspect of the
toxin-binding site; T393 in the domain I SS2-S6 loop may contribute to a sec-
ond part of the site. Modeling the toxin receptor site and the toxin-receptor in-teraction with the Rosetta-Membrane structural-modeling and ligand-docking
algorithms resulted in a three-dimensional model of LqhII binding to the volt-
age sensor of the channel. This model refines the structure of the resting state of
the voltage sensor and suggests its mode of interaction with a gating modifier
toxin. Supported by U01 NS058039.
2287-Pos Board B273
High-Resolution Structural Modeling of Voltage-Dependent Conforma-
tional Changes in the Voltage Sensor of NaChBac
Vladimir M. Yarov-Yarovoy, Paul DeCaen, Todd Scheuer, David Baker,
William A. Catterall.
Progress has been made in determining high-resolution structures of voltage
sensors of voltage-gated ion channels in activated and/or inactivated states.
However, high-resolution structures of resting and intermediate states of volt-
age sensors remain unknown.We constructed high-resolution structural models
of resting, intermediate, and activated states of the voltage-sensing domain
(VSD) of the bacterial sodium channel NaChBac using the Rosetta-
Membrane computational method, the Rosetta method-based FoldIt program,
the x-ray structure of the Kv1.2-Kv2.1 chimeric channel, and experimental
data demonstrating sequential interactions between gating-charge-carrying ar-
ginines in S4 segment and negatively charged residues in S1, S2, and S3 seg-
ments during activation. The resulting sliding helix model suggests that the S4
is a 3-10 helix from the first or second gating-charge-carrying arginine to the
fourth gating-charge-carrying arginine or S125 near its C-terminus during the
conformational change between the resting and activated states. The S4 seg-
ment slides ~10 A˚ through a narrow groove formed by rigid S1, S2 and S3 seg-
ments, rotates ~30-60 degrees with respect to its own axis, and tilts sideways at
a pivot point formed by a highly conserved hydrophobic region in the middle of
the VSD. During S4 movement, gating-charge-carrying arginines sequentially
form ion pairs and hydrogen bonds with highly conserved negatively charged
and polar residues in the narrow gating pore and in the intracellular and extra-
cellular water-accessible cavities of the VSD. Conformational changes of the
intracellular half of S4 are coupled to lateral movement of the S4-S5 linker
that leads to movement of the intracellular half of S5 and S6 segments and ei-
ther opens or closes the intracellular gate of the ion-conducting pore. Supported
by NIH R01 NS015751 to W.A.C. and P20GM076222 to D.B.
2288-Pos Board B274
Disulfide Locking Reveals Interaction of the Gating Charges with a Nega-
tive Charge in the S1 Segment During Activation of the NaChBac Voltage
Sensor
Paul G. DeCaen, Vladimir Yarov-Yarovoy, Todd Scheuer,
William A. Catterall.
Opening and closing the pore of voltage-gated ion channels are mechanically
linked to conformational movement of the positively charged fourth transmem-
brane segment (S4) in the voltage sensor. Disulfide locking of cysteines
substituted for gating charges and for E43 at the extracellular end of the S1 seg-
ment of the bacterial sodium channel NaChBac demonstrated that a threonine
at gating charge position 0 (T0) and arginine at the first gating charge position
(R1) located at the extracellular end of S4 interact with E43 in the closed state,
whereas the second and the third gating charges (R2) and (R3) interact with E43
in activated states. The kinetics and voltage dependence of disulfide locking of
R2C and R3C demonstrate sequential interactions of the gating charges with
E43C during voltage sensor activation. We did not observe disulfide locking
with the fourth or last gating charge (R4) and E43, suggesting that we have de-
scribed the upper limit to the outward movement made by the S4 during chan-
nel activation. These results indicate that S4 moves 8-10A˚ outward with respect
to E43 in the transition from resting to activate states, which supports a sliding
helix model of voltage sensor movement in voltage-gated ion channels.
2289-Pos Board B275
An Alternative Tetramerisation Domain Restores Expression of the
NAChBac Voltage-Gated Sodium Channel
Andrias O. O’Reilly, Andrew M. Powl, B.A. Wallace.
The NaChBac voltage-gated sodium channel from Bacillus halodurans is
a homo-tetramer, whichmatches the quaternary structure of potassium channels
but contrasts with the single-chain mammalian sodium channels. We have pre-
viously demonstrated that the cytoplasmic C-terminus of NaChBac functions as
a channel assembly domain [Powl et al (2010) PNAS 107:14064-14069]. Se-
quential deletion mutations reduce the amount of NaChBac in the membrane
fraction, with removal of the entire C-terminus eliminating the channel assem-
bly. A similar effect was also found upon removal of potassium channel assem-
bly domains. However, potassium channel expression can be rescued by using
an alternative tetramerisation domain replacement.
In this study we generated a chimeric form of NaChBac in which the C-termi-
nus was removed and the short cytoplasmic N-terminus was replaced with the
